When a company splits in two, one side usually ends up renting what it used to own. Which side, and on what terms, is decided in the separation workstream that gets...
October was a month about the gap between owning a right and controlling an outcome. A valid patent on a drug’s mechanism that left its owner with no market. A licence...
Many companies treat IP ownership as something settled after a contract is won. However, a buyer large enough to set the terms can make ownership a condition of bidding. When that...
The price of frontier AI capability is falling towards zero. The consequence for an IP strategy is not that AI has become cheaper. It is that anything you thought you were...
The patent is rarely where the money is decided. The licence is. Three IP developments from the past week make that point, and each turns on terms settled, or left unsettled,...
Adding AI to a product is not a strategy. Moving to where the value is going is. And every real move changes what your company controls, which makes it an IP...
Some assets cannot be built on any timeline a budget can shorten. When that is true, the choice is no longer build, buy or licence. It is licence, or stay out....
Most boards plan around a single date. The patent expires, competitors arrive, the revenue line falls off a ledge. That model is tidy, it sits in the forecast, and for high-value...
Intellectual property rights don’t dissolve the moment you stop paying attention to them. That’s the thread running through several developments last week, and it’s worth more attention than most companies give...
If a capability you spent years building can be downloaded on a Sunday afternoon, the question is not how to stop that. It is what you own that survives it. Ben...
You must be logged in to post a comment.